The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling

Journal of Vascular Surgery

Volumn 58, Issue 5, 2013, Pages

  Deatrick, Kristopher B ^a   Luke, Catherine E ^a   Elfline, Megan A ^a   Sood, Vikram ^a   Baldwin, Joseph ^a   Upchurch Jr , Gilbert R ^a   Jaffer, Farouc A ^b   Wakefield, Thomas W ^a   Henke, Peter K ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; PROCOLLAGEN; PROCOLLAGEN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE DELETION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INFERIOR CAVA VEIN; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROCOLLAGEN 3 GENE; REAL TIME POLYMERASE CHAIN REACTION; VEIN WALL; ZYMOGRAPHY;

EID: 84886597240     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2012.11.088     Document Type: Article

References (41)

1. D. Lloyd-Jones, R.J. Adams, T.M. Brown, M. Carnethon, S. Dai, and G. De Simone Heart disease and stroke statistics-2010 update. A report from the American Heart Association Circulation 121 2010 e46 e215
2. J.J. Bergan, G.W. Schmid-Schonbein, P.D. Smith, A.N. Nicolaides, M.R. Boisseau, and B. Eklof Chronic venous disease N Engl J Med 355 2006 488 498
3. B.F. Johnson, R.A. Manzo, R.O. Bergelin, and D.E. Strandness Jr. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up J Vasc Surg 21 1995 307 312 discussion: 313
4. P.K. Henke, and A.J. Comerota An update on etiology, prevention, and therapy of postthrombotic syndrome J Vasc Surg 53 2011 500 509
5. P.K. Henke, M.R. Varma, D.K. Moaveni, N.A. Dewyer, A.J. Moore, and E.M. Lynch Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis Thromb Haemost 98 2007 1045 1055
6. K.B. Deatrick, J.L. Eliason, E.M. Lynch, A.J. Moore, N.A. Dewyer, and M.R. Varma Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model J Vasc Surg 42 2005 140 148
7. S. Dahi, J.G. Lee, D.H. Lovett, and R. Sarkar Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin J Vasc Surg 42 2005 539 545
8. P.K. Henke, M.R. Varma, K.B. Deatrick, N.A. Drewyer, E.M. Lynch, and A.J. Moore Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization Thromb Haemost 95 2006 272 281
9. C.M. Ripplinger, C.W. Kessinger, C. Li, J.W. Kim, J.R. McCarthy, and R. Weissleder Inflammation modulates murine venous thrombosis resolution in vivo: assessment by multimodal fluorescence molecular imaging Arterioscler Thromb Vasc Biol 32 2012 2616 2624
10. N.A. Dewyer, V. Sood, E.M. Lynch, C.E. Luke, G.R. Upchurch Jr., and T.W. Wakefield Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution J Surg Res 142 2007 357 363
11. V. Sood, C. Luke, E. Miller, M. Mitsuya, G.R. Upchurch Jr., and T.W. Wakefield Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline Ann Vasc Surg 24 2010 233 241
12. D.B. Corry, A. Kiss, L.Z. Song, L. Song, J. Xu, and S.H. Lee Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased cc chemokines FASEB J 18 2004 995 997
13. K.B. Deatrick, M. Elfline, N. Baker, C.E. Luke, S. Blackburn, and C. Stabler Postthrombotic vein wall remodeling: preliminary observations J Vasc Surg 53 2011 139 146
14. P.K. Henke, A. Varga, S. De, C.B. Deatrick, J. Eliason, and D.A. Arenberg Deep vein thrombosis resolution is modulated by monocyte cxcr2-mediated activity in a mouse model Arterioscler Thromb Vasc Biol 24 2004 1130 1137
15. P.K. Henke, C.G. Pearce, D.M. Moaveni, A.J. Moore, E.M. Lynch, and C. Longo Targeted deletion of ccr2 impairs deep vein thombosis resolution in a mouse model J Immunol 177 2006 3388 3397
16. P.K. Henke, M. Mitsuya, C.E. Luke, M.A. Elfline, J.F. Baldwin, and K.B. Deatrick Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution Arterioscler Thromb Vasc Biol 31 2011 43 49
17. M.K. Siu, and C.Y. Cheng Interactions of proteases, protease inhibitors, and the beta1 integrin/laminin gamma3 protein complex in the regulation of ectoplasmic specialization dynamics in the rat testis Biol Reprod 70 2004 945 964
18. V. Sood, C.E. Luke, K.B. Deatrick, J. Baldwin, E.M. Miller, and M. Elfline Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism Thromb Haemost 104 2010 1174 1183
19. L.C. Junqueira, G. Bignolas, and R.R. Brentani Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections Histochem J 11 1979 447 455
20. L. Cuttle, M. Nataatmadja, J.F. Fraser, M. Kempf, R.M. Kimble, and M.T. Hayes Collagen in the scarless fetal skin wound: detection with picrosirius-polarization Wound Repair Regen 13 2005 198 204
21. J.F. Baldwin, V. Sood, M.A. Elfline, C.E. Luke, N.A. Dewyer, and J.A. Diaz The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis J Vasc Surg 56 2012 1089 1097
22. D.D. Myers Jr., P.K. Henke, P.W. Bedard, S.K. Wrobleski, N. Kaila, and G. Shaw Treatment with an oral small molecule inhibitor of p selectin (psi-697) decreases vein wall injury in a rat stenosis model of venous thrombosis J Vasc Surg 44 2006 625 632
23. D.K. Moaveni, E.M. Lynch, C. Luke, V. Sood, G.R. Upchurch, and T.W. Wakefield Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin J Vasc Surg 47 2008 616 624
24. W.C. Parks, C.L. Wilson, and Y.S. Lopez-Boado Matrix metalloproteinases as modulators of inflammation and innate immunity Nat Rev Immunol 4 2004 617 629
25. Z.S. Galis, and J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly Circ Res 90 2002 251 262
26. A. Cho, and M.A. Reidy Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury Circ Res 91 2002 845 851
27. J. Zhang, L. Nie, M. Razavian, M. Ahmed, L.W. Dobrucki, and A. Asadi Molecular imaging of activated matrix metalloproteinases in vascular remodeling Circulation 118 2008 1953 1960
28. M.S. Pepper Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis Arterioscler Thromb Vasc Biol 21 2001 1104 1117
29. I. Singh, K.G. Burnand, M. Collins, A. Luttun, D. Collen, and B. Boelhouwer Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells Circulation 107 2003 869 875
30. C. Johnson, and Z.S. Galis Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization Arterioscler Thromb Vasc Biol 24 2004 54 60
31. M. Kuzuya, S. Kanda, T. Sasaki, N. Tamaya-Mori, X.W. Cheng, and T. Itoh Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia Circulation 108 2003 1375 1381
32. J.L. Johnson, A. Dwivedi, M. Somerville, S.J. George, and A.C. Newby Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice Arterioscler Thromb Vasc Biol 31 2011 e35 e44
33. C. Castagnoli, M. Stella, C. Berthod, G. Magliacani, and P.M. Richiardi TNF production and hypertrophic scarring Cell Immunol 147 1993 51 63
34. R.S. Bienkowski, and M.G. Gotkin Control of collagen deposition in mammalian lung Proc Soc Exp Biol Med 209 1995 118 140
35. P.M. Cummins, N. von Offenberg Sweeney, M.T. Killeen, Y.A. Birney, E.M. Redmond, and P.A. Cahill Cyclic strain-mediated matrix metalloproteinase regulation within the vascular endothelium: a force to be reckoned with Am J Physiol Heart Circ Physiol 292 2007 H28 H42
36. J.S. Ikonomidis, W.C. Gibson, J.E. Butler, D.M. McClister, S.E. Sweterlitsch, and R.P. Thompson Effects of deletion of the tissue inhibitor of matrix metalloproteinases-1 gene on the progression of murine thoracic aortic aneurysms Circulation 110 2004 II-268 II-273
37. B. Vaillant, M.G. Chiaramonte, A.W. Cheever, P.D. Soloway, and T.A. Wynn Regulation of hepatic fibrosis and extracellular matrix genes by the th response: new insight into the role of tissue inhibitors of matrix metalloproteinases J Immunol 167 2001 7017 7026
38. T.A. Wynn, and L. Barron Macrophages: master regulators of inflammation and fibrosis Semin Liver Dis 30 2010 245 257
39. D.D. Myers Jr., S.K. Wrobleski, C. Longo, P.W. Bedard, N. Kaila, and G.D. Shaw Resolution of venous thrombosis using a novel oral small-molecule inhibitor of p-selectin (psi-697) without anticoagulation Thromb Haemost 97 2007 400 407
40. A. Berton, V. Rigot, E. Huet, M. Decarme, Y. Eeckhout, and L. Patthy Involvement of fibronectin type ii repeats in the efficient inhibition of gelatinases a and b by long-chain unsaturated fatty acids J Biol Chem 276 2001 20458 20465
41. R. Visse, and H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry Circ Res 92 2003 827 839